Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Covid-19 With Favipiravir Versus Hydroxychloroquine: a Randomized Comparator Trial

NCT04387760 is registered in ClinicalTrials.gov with Royal College of Surgeons in Ireland - Medical University of Bahrain as lead sponsor.

NCT NCT04387760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04387760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Covid-19 With Favipiravir Versus Hydroxychloroquine: a Randomized Comparator Trial
Lead sponsor
Royal College of Surgeons in Ireland - Medical University of Bahrain
Phase
Phase 2
Overall status
Completed
Start date
August 11, 2020
Completion date
April 7, 2021
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov 2